Greenwich LifeSciences, Inc.
GLSI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,152 | -$4,025 | -$3,258 | -$8,040 |
| Dep. & Amort. | $0 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,544 | $1,544 | $1,544 | $5,470 |
| Change in WC | -$64 | $247 | -$121 | $717 |
| Other Non-Cash | $0 | $0 | $0 | $0 |
| Operating Cash Flow | -$2,671 | -$2,233 | -$1,834 | -$1,852 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,208 | $2,608 | $492 | $122 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $145 | $0 | $0 | $0 |
| Financing Cash Flow | $3,353 | $2,608 | $492 | $122 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $682 | $375 | -$1,342 | -$1,730 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,125 | $2,750 | $4,092 | $5,822 |
| End Cash | $3,807 | $3,125 | $2,750 | $4,092 |
| Free Cash Flow | -$2,671 | -$2,233 | -$1,834 | -$1,852 |